A Roche drug that is one of the company’s top cancer products is expanding to autoimmune disease with a new FDA approval in lupus nephritis. The intravenously infused drug, Gazyva, may now be used to ...
Belimumab can reduce the glucocorticoid burden in patients with lupus nephritis, real-world data show. A majority of real-world patients with lupus nephritis (LN) who start belimumab are able to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results